{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:50Z","timestamp":1794274190720,"version":"4.9.0"},"reference-count":137,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Malaria is one of the most life-threatening infectious diseases and constitutes a major health problem, especially in Africa. Although artemisinin combination therapies remain efficacious to treat malaria, the emergence of resistant parasites emphasizes the urgent need of new alternative chemotherapies. One strategy is the repurposing of existing drugs. Herein, we reviewed the antimalarial effects of marketed antibiotics, and described in detail the fast-acting antibiotics that showed activity in nanomolar concentrations. Antibiotics have been used for prophylaxis and treatment of malaria for many years and are of particular interest because they might exert a different mode of action than current antimalarials, and can be used simultaneously to treat concomitant bacterial infections.<\/jats:p>","DOI":"10.3390\/molecules26082304","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T21:35:13Z","timestamp":1618522513000},"page":"2304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action"],"prefix":"10.3390","volume":"26","author":[{"given":"Lais","family":"Pessanha de Carvalho","sequence":"first","affiliation":[{"name":"Institute of Tropical Medicine, University of Tuebingen, 72074 Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-7221","authenticated-orcid":false,"given":"Andrea","family":"Kreidenweiss","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine, University of Tuebingen, 72074 Tuebingen, Germany"},{"name":"Centre de Recherches Medicales de Lambar\u00e9n\u00e9 (CERMEL), Lambar\u00e9n\u00e9 BP 242, Gabon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine, University of Tuebingen, 72074 Tuebingen, Germany"},{"name":"Centre de Recherches Medicales de Lambar\u00e9n\u00e9 (CERMEL), Lambar\u00e9n\u00e9 BP 242, Gabon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"ref_1","unstructured":"(2021, January 26). World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240015791."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2015.00391","article-title":"Enlightening the malaria parasite life cycle: Bioluminescent Plasmodium in fundamental and applied research","volume":"6","author":"Siciliano","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_3","first-page":"1","article-title":"Inducing controlled cell cycle arrest and re-entry during asexual proliferation of Plasmodium falciparum malaria parasites","volume":"8","author":"Niemand","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/2047773215Y.0000000013","article-title":"Killing the hypnozoite \u2014 drug discovery approaches to prevent relapse in Plasmodium vivax","volume":"109","author":"Campo","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2014.00104","article-title":"The systemic pathology of cerebral malaria in African children","volume":"4","author":"Milner","year":"2014","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_6","unstructured":"(2021, January 26). World Health Organization. Available online: https:\/\/www.who.int\/malaria\/publications\/atoz\/rectal-artesunate-severe-malaria\/en\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17460441.2020.1804357","article-title":"The preclinical discovery and development of rectal artesunate for the treatment of malaria in young children: A review of the evidence","volume":"16","author":"Carvalho","year":"2021","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_8","unstructured":"(2021, January 26). World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241549127."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.pt.2019.08.009","article-title":"Killing of Plasmodium vivax by primaquine and tafenoquine","volume":"35","author":"Markus","year":"2019","journal-title":"Trends Parasitol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.4269\/ajtmh.19-0379","article-title":"Origin and spread of evolving artemisinin-resistant Plasmodium falciparum malarial parasites in Southeast Asia","volume":"101","author":"Hassett","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006230","article-title":"Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries","volume":"12","author":"Recht","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/IDR.S151031","article-title":"Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: A review on the mode of action and emerging trial data","volume":"12","author":"Hounkpatin","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","article-title":"Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: A systematic review and meta-analysis","volume":"19","author":"Larsen","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","unstructured":"(2021, January 26). Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/malaria\/travelers\/drugs.html."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","article-title":"Challenges and opportunities with drug repurposing: Finding strategies to find alternative uses of therapeutics","volume":"15","author":"Talevi","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: A brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: A guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1613-y","article-title":"Antibiotics in malaria therapy: Which antibiotics except tetracyclines and macrolides may be used against malaria?","volume":"15","author":"Gaillard","year":"2016","journal-title":"Malar. J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fontinha, D., Moules, I., and Prudencio, M. (2020). Repurposing drugs to fight hepatic malaria parasites. Molecules, 25.","DOI":"10.3390\/molecules25153409"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/cid\/ciaa732","article-title":"Bacterial coinfection in adults with severe malaria","volume":"72","author":"Aung","year":"2021","journal-title":"Clin. Infec. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-12-31","article-title":"Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: A systematic review","volume":"12","author":"Church","year":"2014","journal-title":"BMC Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/156652410791065273","article-title":"Antibiotics in malaria therapy and their effect on the parasite apicoplast","volume":"10","author":"Pradel","year":"2010","journal-title":"Curr. Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1098\/rstb.2009.0273","article-title":"The evolution, metabolism and functions of the apicoplast","volume":"365","author":"Lim","year":"2010","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-015-0162-0","article-title":"Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum","volume":"13","author":"Wilson","year":"2015","journal-title":"BMC Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrmicro843","article-title":"Metabolic maps and functions of the Plasmodium falciparum apicoplast","volume":"2","author":"Ralph","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0020-7519(02)00022-X","article-title":"Biogenesis of iron \u2014 sulphur clusters in amitochondriate and apicomplexan protists","volume":"32","author":"Seeber","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1073\/pnas.95.21.12352","article-title":"Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum","volume":"95","author":"Waller","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molbiopara.2015.03.004","article-title":"Fatty acid metabolism in the Plasmodium apicoplast: Drugs, doubts and knockouts","volume":"199","author":"Shears","year":"2015","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.M114.615831","article-title":"The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages","volume":"289","author":"Ke","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"34827","DOI":"10.1128\/AAC.01161-17","article-title":"Validation of putative apicoplast-targeting drugs using a chemical supplementation assay in cultured human malaria","volume":"62","author":"Uddin","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.pt.2019.07.010","article-title":"Delayed death by plastid inhibition in apicomplexan parasites","volume":"35","author":"Kennedy","year":"2019","journal-title":"Trends Parasitol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-7-4","article-title":"The costs of introducing artemisinin-based combination therapy: Evidence from district-wide implementation in rural Tanzania","volume":"7","author":"Njau","year":"2008","journal-title":"Malar. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1054\/drup.1998.0060","article-title":"The mechanism of resistance to sulfa drugs in Plasmodium falciparum","volume":"2","author":"Triglia","year":"1999","journal-title":"Drug Resist. Updat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.84.23.8360","article-title":"Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene","volume":"84","author":"Bzik","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0020-7519(90)90198-V","article-title":"Chemotherapy and drug resistance in malaria","volume":"20","author":"Cowman","year":"1990","journal-title":"Int. J. Parasitol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/emboj\/17.14.3807","article-title":"Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria","volume":"17","author":"Triglia","year":"1998","journal-title":"EMBO J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2958.1997.2821646.x","article-title":"Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization","volume":"23","author":"Wang","year":"1997","journal-title":"Mol. Microbiol."},{"key":"ref_43","unstructured":"(2021, January 26). World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240012813."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/clinids\/24.Supplement_1.S63","article-title":"Increases in rates of resistance to trimethoprim","volume":"24","author":"Huovinen","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","first-page":"536","article-title":"The biosynthesis of folic acid","volume":"249","author":"Brown","year":"1963","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Manyando, C., Njunju, E.M., D\u2019Alessandro, U., and Van Geertruyden, J.-P. (2013). Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: Asystematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056916"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/QAD.0b013e3282ef6da1","article-title":"Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children","volume":"21","author":"Kamya","year":"2007","journal-title":"AIDS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d1617","article-title":"Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: A randomised clinical trial","volume":"342","author":"Sandison","year":"2011","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(06)68541-3","article-title":"Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: A prospective cohort study","volume":"367","author":"Mermin","year":"2006","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00034983.1971.11686737","article-title":"Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren","volume":"65","author":"Fasan","year":"1971","journal-title":"Ann. Trop Med. Parasitol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/S0074-02762005000400019","article-title":"Effects of antifolates \u2014 co-trimoxazole and pyrimethamine- sulfadoxine\u2014on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria","volume":"100","author":"Sowunmi","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2005.73.609","article-title":"Efficacy of trimethroprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia","volume":"73","author":"Hamel","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1086\/498249","article-title":"Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease","volume":"192","author":"Thera","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/tmi.12352","article-title":"Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: Systematic review and meta-analysis","volume":"19","author":"Mbeye","year":"2015","journal-title":"Trop. Med. Int. Health"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S2214-109X(19)30422-X","article-title":"Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: A randomised controlled, non-inferiority trial","volume":"7","author":"Daniels","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_56","first-page":"1","article-title":"The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance","volume":"13","author":"Menten","year":"2008","journal-title":"Malar. J."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Juma, D.W., Muiruri, P., Yuhas, K., John-Stewart, G., Ottichilo, R., Waitumbi, J., Singa, B., Polyak, C., and Kamau, E. (2019). The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007223"},{"key":"ref_58","unstructured":"(2021, January 29). MMV-Supported Projects. Available online: https:\/\/www.mmv.org\/research-development\/mmv-supported-projects."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.15190\/d.2019.15","article-title":"FDA approved antibacterial drugs: 2018-2019","volume":"7","author":"Andrei","year":"2019","journal-title":"Discoveries"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0005-2787(67)90494-7","article-title":"Partial removal of bound transfer RNA from polysomes engaged in protein synthesis in vitro after addition of tetracycline","volume":"138","author":"Maxwell","year":"1967","journal-title":"Biochim. Biophys. Acta (BBA) Nucleic Acids Protein Synth."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/emboj\/20.8.1829","article-title":"Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3","volume":"20","author":"Pioletti","year":"2001","journal-title":"EMBO J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-4632.2004.02108.x","article-title":"Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity","volume":"43","author":"Rogers","year":"2004","journal-title":"Int J. Dermatol."},{"key":"ref_64","first-page":"377","article-title":"Studies in human malaria. XXIX. Trials of aureomycin, chloramphenicol, penicillin, and dihydrostreptomycin against the Chesson strain of Plasmodium vivax","volume":"9","author":"Imboden","year":"1950","journal-title":"J. Natl. Malar. Soc."},{"key":"ref_65","first-page":"10","article-title":"Terramycin in malaria therapy","volume":"59","author":"Sanchez","year":"1952","journal-title":"Pan. Am. Med. Womans. J."},{"key":"ref_66","first-page":"193196","article-title":"The treatment of malaria with tetracycline","volume":"3","author":"Grande","year":"1956","journal-title":"Antibiot. Med. Clin. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","article-title":"Doxycycline for malaria chemoprophylaxis and treatment: Report from the CDC expert meeting on malaria chemoprophylaxis","volume":"84","author":"Tan","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/AAC.00312-09","article-title":"Antimalarial activity of tigecycline, a novel glycylcycline antibiotic","volume":"53","author":"Starzengruber","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/0037-8682-0013-2012","article-title":"In vitro antimalarial activity of tigecycline against Plasmodium falciparum culture-adapted reference strains and clinical isolates from the Brazilian Amazon","volume":"47","author":"Bassi","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijantimicag.2010.02.003","article-title":"In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon","volume":"35","author":"Held","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/AAC.01499-05","article-title":"Functional, biophysical, and structural bases for antibacterial activity of tigecycline","volume":"50","author":"Held","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","first-page":"1","article-title":"In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine","volume":"414","author":"Sahu","year":"2014","journal-title":"Malar. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jgar.2020.11.024","article-title":"In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum","volume":"24","author":"Koehne","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41589-019-0343-1","article-title":"Fosmidomycin biosynthesis diverges from related phosphonate natural products","volume":"15","author":"Parkinson","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/AAC.00382-11","article-title":"A promising target for treatment of multidrug-resistant bacterial infections","volume":"55","author":"Davey","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","unstructured":"Phu, N.H., Day, N.P.J., Tuan, P.Q., Mai, N.T.H., Chau, T.T.H., Van Chuong, L., Vinh, H., Loc, P.P., Sinh, D.X., and Hoa, N.T.T. (2020). Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J. Antibiot., 71."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1016\/S0040-4039(98)01755-9","article-title":"Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis","volume":"39","author":"Kuzuyama","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1128\/AAC.00602-15","article-title":"Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr)","volume":"59","author":"Armstrong","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs","volume":"285","author":"Jomaa","year":"1999","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.21.2.224","article-title":"Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic","volume":"21","author":"Murakawa","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.47.2.735-738.2003","article-title":"Fosmidomycin, a novel chemotherapeutic agent for malaria","volume":"47","author":"Lell","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(02)11860-5","article-title":"Fosmidomycin for malaria","volume":"360","author":"Missinou","year":"2002","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1128\/AAC.46.9.2889-2894.2002","article-title":"In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin","volume":"46","author":"Wiesner","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_84","first-page":"1","article-title":"Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria","volume":"7","author":"Ruengweerayut","year":"2008","journal-title":"Malar. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/381785","article-title":"Fosmidomycin-clindamycin for Plasmodium falciparum infections in African children","volume":"189","author":"Borrmann","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/AAC.01448-06","article-title":"Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria","volume":"51","author":"Oyakhirome","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/AAC.00392-06","article-title":"Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria","volume":"50","author":"Borrmann","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1128\/AAC.00018-12","article-title":"Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria","volume":"56","author":"Lanaspa","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/AAC.49.9.3749-3754.2005","article-title":"Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria","volume":"49","author":"Borrmann","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jeli\u0107, D., and Antolovi\u0107, R. (2016). From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics, 5.","DOI":"10.3390\/antibiotics5030029"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ja.2007.10","article-title":"Azalides from azithromycin to new azalide derivatives","volume":"60","author":"Mutak","year":"2007","journal-title":"J. Antibiot."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15958","DOI":"10.1073\/pnas.1417334111","article-title":"The general mode of translation inhibition by macrolide antibiotics","volume":"111","author":"Kannan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.56.727","article-title":"In vitro and in vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia","volume":"56","author":"Otoguro","year":"2003","journal-title":"J. Antibiot."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.11-187401","article-title":"Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches","volume":"25","author":"Ekland","year":"2011","journal-title":"FASEB J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/138920112800399095","article-title":"History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents","volume":"13","author":"Campbell","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin, \u2018Wonder drug\u2019 from Japan: The human use perspective","volume":"87","author":"Crump","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref_97","first-page":"374","article-title":"Comparison of ivermectin and albendazole treatment for gnathostomiasis","volume":"31","author":"Nontasut","year":"2000","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0103-64402004000100015","article-title":"Oral myiasis treated with ivermectin: Case report","volume":"15","author":"Shinohara","year":"2004","journal-title":"Braz. Dent. J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1525-1470.2010.01317.x","article-title":"A pilot study of the use of oral ivermectin to treat head lice in primary school students in Australia","volume":"27","author":"Currie","year":"2010","journal-title":"Pediatr. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4269\/ajtmh.1989.40.304","article-title":"Ivermectin for human strongyloidiasis and other intestinal helminths","volume":"40","author":"Naquira","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01696-12","article-title":"Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains","volume":"57","author":"Lim","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0169-4758(85)90100-0","article-title":"Ivermemctin: An update","volume":"1","author":"Campbell","year":"1985","journal-title":"Parasitol. Today"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e994-11","DOI":"10.1038\/cddis.2013.521","article-title":"Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP","volume":"5","author":"Panchal","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_104","unstructured":"(2021, January 26). Mectizan Donation Program. Available online: https:\/\/mectizan.org\/news-resources\/2015-annual-highlights\/#."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Ejere, H.O.D., Schwartz, E., and Wormald, R. (2012). Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD002219.pub2"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trstmh.2003.10.018","article-title":"Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly","volume":"98","author":"Kamgno","year":"2004","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pt.2014.07.005","article-title":"Ivermectin: Panacea for resource-poor communities?","volume":"30","author":"Omura","year":"2014","journal-title":"Trends Parasitol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Mackenzie, C.D., Geary, T.G., and Gerlach, J.A. (2003). Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J., 2.","DOI":"10.1186\/1475-2883-2-S1-S5"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"ref_110","first-page":"1","article-title":"Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments","volume":"417","author":"Alout","year":"2014","journal-title":"Malar. J."},{"key":"ref_111","first-page":"1","article-title":"Screening for an ivermectin slow-release formulation suitable for malaria vector control","volume":"102","author":"Chaccour","year":"2015","journal-title":"Malar. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/cid\/ciu802","article-title":"Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission","volume":"60","author":"Steketee","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: The potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2011.05.007","article-title":"Endectocides for malaria control","volume":"27","author":"Foy","year":"2011","journal-title":"Trends Parasitol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006221","article-title":"Promising approach to reducing malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi","volume":"12","author":"Pinilla","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1923-8","article-title":"Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles","volume":"16","author":"Kobylinski","year":"2017","journal-title":"Malar. J."},{"key":"ref_117","first-page":"1","article-title":"Ivermectin inhibits and delays the development of Plasmodium falciparum in Anopheles gambiae","volume":"381","author":"Kobylinski","year":"2012","journal-title":"Am. J. Trop Med. Hyg."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): A cluster-randomised trial","volume":"393","author":"Foy","year":"2019","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Dabira, E.D., Soumare, H.M., Lindsay, S.W., Conteh, B., Ceesay, F., Bradley, J., Kositz, C., Broekhuizen, H., Kandeh, B., and Fehr, A.E. (2020). Mass drug administration with high-dose ivermectin and dihydroartemisinin-piperaquine for malaria elimination in an area of low transmission with high coverage of malaria control interventions: Protocol for the massiv cluster randomized clinical trial. JMIR Res. Protoc., 9e20904.","DOI":"10.2196\/20904"},{"key":"ref_120","first-page":"1","article-title":"Ivermectin impairs the development of sexual and asexual stages of Plasmodium falciparum in vitro","volume":"63","author":"Sandri","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02005-16","article-title":"Inhibition of Plasmodium liver infection by ivermectin","volume":"61","author":"Mendes","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tmi.13357","article-title":"Ivermectin for causal malaria prophylaxis: A randomised controlled human infection trial","volume":"25","author":"Metzger","year":"2020","journal-title":"Trop. Med. Int. Heal."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.2196\/resprot.6617","article-title":"Efficacy and safety of high-dose ivermectin for reducing malaria transmission (IVERMAL): Protocol for a double-blind, randomized, placebo-controlled, dose-finding trial in Western Kenya","volume":"5","author":"Smit","year":"2016","journal-title":"JMIR Res. Protoc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1473-3099(18)30163-4","article-title":"Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): A randomised, double-blind, placebo-controlled trial","volume":"18","author":"Smit","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_125","first-page":"1","article-title":"Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers","volume":"12","author":"Ballester","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adults subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bcp.13840","article-title":"Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers","volume":"85","author":"Duthaler","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/acs.jmedchem.0c00033","article-title":"Molecular design and synthesis of ivermectin hybrids targeting hepatic and erythrocytic stages of Plasmodium parasites","volume":"63","author":"Singh","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcp.2016.12.001","article-title":"Lincosamides: Chemical structure, biosynthesis, mechanism of action, resistance and applications","volume":"133","author":"Rezanka","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1039\/C6SC04235J","article-title":"Elucidation of salicylate attachment in celesticetin biosynthesis opens the door to create a library of more efficient hybrid lincosamide antibiotics","volume":"8","author":"Kadlcik","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1021\/ja308221z","article-title":"Construction of the octose 8-phosphate intermediate in Lincomycin A biosynthesis: Characterization of the reactions catalyzed by LmbR and LmbN","volume":"134","author":"Sasaki","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","article-title":"Clindamycin as an antimalarial drug: Review of clinical trials","volume":"46","author":"Lell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.01090-09","article-title":"In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon","volume":"54","author":"Held","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-68","article-title":"Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan","volume":"13","author":"Vento","year":"2013","journal-title":"BMC Infect Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-325","article-title":"Staphylococcus aureus colonization of healthy military service members in the United States and Afghanistan","volume":"13","author":"Vento","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"ref_137","first-page":"465","article-title":"Concomitant bacteremia in adults with severe falciparum malaria","volume":"71","author":"Phu","year":"2020","journal-title":"Clin. Infect. Dis."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/8\/2304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:48:35Z","timestamp":1760161715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/8\/2304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":137,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["molecules26082304"],"URL":"https:\/\/doi.org\/10.3390\/molecules26082304","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}